Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesDifferences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient Outcome
Cancer Research, 10/21/09
Menetrier–Caux C et al. – The presence of regulatory T cells (Treg) has been described in a large panel of solid tumors. However, their impact on tumor progression differs according to the tumor type analyzed. Here, the authors discuss the meaning and potential implication of these novel findings.
Related Articles
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Journal of Clinical Oncology, 10/12/09
Relevance Score: 67%
HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants
Journal of Leukocyte Biology, 11/12/09
Relevance Score: 65%
CCR7 Deficiency Exacerbates Injury in Acute Nephritis Due to Aberrant Localization of Regulatory T Cells
Journal of the American Society of Nephrology, 11/18/09
Relevance Score: 64%
Primary cutaneous marginal zone lymphoma
Critical Reviews in Oncology/Hematology, 10/15/09
Relevance Score: 63%
Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Arthritis Research & Therapy, 10/14/09
Relevance Score: 48%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Clinical Cancer Research, 12/01/09
A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Clinical Cancer Research, 12/01/09
Tacrolimus enhances transforming growth factor-[beta]1 expression and promotes tumor progression
Transplantation, 12/01/09
Sponsor
Article Search
Sponsor